Powl Brian T.

Chief Commercial Officer

Powl Brian T. has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.

On the most recent filing, Powl Brian T. is listed as Chief Commercial Officer at Kura Oncology, Inc. Inside the rolling window, Powl Brian T. reported no open-market purchases and 6 open-market sales totaling $398K in KURA. The largest disclosed transaction in the window is a sale of 10,000 KURA shares on May 21, 2026, worth $110K.

Companies traded

Other insiders at KURA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$398K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KURASale$52KAug 24SEC ↗
KURASale$110KMay 22SEC ↗
KURASale$3KMay 20SEC ↗
KURASale$54KJan 27SEC ↗
KURASale$99KNov 14SEC ↗
KURASale$80KSep 29SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Powl Brian T. made?

Powl Brian T. has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does Powl Brian T. trade?

Powl Brian T. has filed SEC Form 4 disclosures for 1 company, including KURA.

When was Powl Brian T.'s most recent SEC Form 4 filing?

Powl Brian T.'s most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.

What is Powl Brian T.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Powl Brian T. is listed as Chief Commercial Officer.

What is Powl Brian T.'s total buy and sell value in the current window?

Inside the rolling retention window, Powl Brian T. bought $0 and sold $398K based on SEC Form 4 filings.

What was Powl Brian T.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 KURA shares on 2026-05-21, worth $110K, per SEC Form 4 filings.